Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Chinese Chip Stocks Jump as Apple Reportedly Tests CXMT Memory Chips for China Devices 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement 
Oil and LNG Tankers Turn Back as Strait of Hormuz Security Risks Escalate 
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest 
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow 
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside 
Telenor to Buy Controlling Stake in Bahnhof in $630 Million Broadband Deal 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 
LAGUNA HILLS, Calif., April 24, 2018 -- With Root Canal Awareness Week just eleven days away, Sonendo®, the developer of the GentleWave® System, has achieved a significant milestone by shipping more than 50,000 GentleWave Procedure Instruments to endodontists in the United States.
The timing of the achievement, is notable, given the proximity to both the upcoming US consumer Root Canal Awareness Week, 6-12 May 2018, and the American Association of Endodontists (AAE) annual meeting which will take place this week, 25-28 April 2018, in Denver, Colorado.
About this milestone, Bjarne Bergheim, President & CEO of Sonendo, stated, “We are excited by the market response to the GentleWave System - both from patients and endodontists alike. We look forward to sharing more exciting results at this year’s AAE annual meeting.”
According to an AAE survey, patient apprehension about getting a standard root canal remains high. The GentleWave Procedure continues to receive positive testimonials from patients pleased with their results and likely to recommend the procedure to friends and family who may need a root canal.
About Sonendo
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy and treatment efficiency when compared to standard root canal techniques.1,2
1Sigurdsson A et al. (2016) J Endod. 42:1040-48. 2Molina B et al. (2015) J Endod. 41:1701-05.
Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.
Media Contact:
Bob Guyatt
Vice President of Marketing
949.766.3636
